Breaking News Instant updates and real-time market news.

USCR

U.S. Concrete

$77.80

-2.05 (-2.57%)

06:12
08/08/17
08/08
06:12
08/08/17
06:12

U.S. Concrete reports Q2 adj. EPS 95c, consensus 86c

Reports Q2 revenue $340.9M, consensus $341.14M.

  • 08

    Aug

  • 11

    Sep

USCR U.S. Concrete
$77.80

-2.05 (-2.57%)

03/24/17
STFL
03/24/17
NO CHANGE
Target $76
STFL
Buy
U.S. Concrete news communicated poorly, but nothing 'sinister,' says Stifel
After U.S. Concrete announced that its CFO was resigning, the board changed accounting firms and that its 2015 financial statements needed to be restated, Stifel analyst Stanley Elliott said he views this as "a series of poorly handled and poorly timed corporate communication" and not "something more sinister." Elliott, who expects little change to U.S. Concrete's strategy over the near or longer-term, sees the weakness as a buying opportunity and keeps a Buy rating on the stock, which is down 11% to $59.30 in morning trading.
03/29/17
DADA
03/29/17
NO CHANGE
Target $80
DADA
Buy
U.S. Concrete recent weakness a buying opportunity, says DA Davidson
DA Davidson analyst Brent Thielman believes U.S. Concrete's recent disclosure of auditor change and the CFO resignation are unrelated and raises unnecessary concerns and said the move to big 4 independent auditor E&Y would not have occurred had there been a material concern by the firm. The analyst said U.S. Concrete has significant capital available to deploy and could attract a new DVO with more extensive M&A and/or materials industry experience and views the recent pullback as a buying opportunity. Thielman rates U.S. Concrete a Buy with an $80 price target.
05/05/17
DADA
05/05/17
NO CHANGE
DADA
U.S. Concrete reported 'blowout results,' says DA Davidson
DA Davidson analyst Brent Thielman says that U.S. Concrete reported "blowout" results. The analyst says that its "strategy of dominating share in local markets appears to be effective." He raised his price target on the stock to $85 from $80 and keeps a Buy rating on the shares.
06/21/17
RHCO
06/21/17
NO CHANGE
RHCO
U.S. Concrete EPS 'on track to double,' says SunTrust
SunTrust analyst Rohit Seth says that U.S. Concrete's EPS is 'on track to (at least) double over the next two years." Seth expects the company's Q2 results to beat expectations. The analyst calls the stock's valuation attractive and labels the shares "a compelling Buy."

TODAY'S FREE FLY STORIES

$NYE

NYSE Market Internals

$0.00

(0.00%)

12:16
12/10/18
12/10
12:16
12/10/18
12:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APC

Anadarko

$49.62

-2.44 (-4.69%)

12:15
12/10/18
12/10
12:15
12/10/18
12:15
Options
Anadarko put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

CCK

Crown Holdings

$47.82

-0.22 (-0.46%)

12:14
12/10/18
12/10
12:14
12/10/18
12:14
Conference/Events
Crown Holdings to host investor meeting »

Investor meeting to be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NRDXF

Nordex

$0.00

(0.00%)

12:13
12/10/18
12/10
12:13
12/10/18
12:13
Upgrade
Nordex rating change  »

Nordex upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:10
12/10/18
12/10
12:10
12/10/18
12:10
General news
FX Action: USD-JPY »

FX Action: USD-JPY…

KO

Coca-Cola

$48.84

-0.24 (-0.49%)

12:08
12/10/18
12/10
12:08
12/10/18
12:08
Periodicals
Coca-Cola hires broker to sell iconic Fifth Avenue building, Bloomberg says »

Coca-Cola has enlisted…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

  • 18

    Dec

  • 03

    Mar

DLAKY

Lufthansa

$0.00

(0.00%)

, EADSY

Airbus

$0.00

(0.00%)

12:07
12/10/18
12/10
12:07
12/10/18
12:07
Periodicals
Avianca CEO wants to cut Airbus order by as much as half, Reuters says »

Avianca Holdings (AVH)…

DLAKY

Lufthansa

$0.00

(0.00%)

EADSY

Airbus

$0.00

(0.00%)

AVH

Avianca

$4.91

-0.39 (-7.36%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$165.25

-3.12 (-1.85%)

, QCOM

Qualcomm

$58.05

2.05 (3.66%)

12:06
12/10/18
12/10
12:06
12/10/18
12:06
OnTheFly
Fly Intel: Wall Street's top stories at midday »

The averages were…

AAPL

Apple

$165.25

-3.12 (-1.85%)

QCOM

Qualcomm

$58.05

2.05 (3.66%)

FB

Facebook

$140.74

3.32 (2.42%)

GPRO

GoPro

$4.94

-0.04 (-0.80%)

TVPT

Travelport

$15.68

0.275 (1.79%)

NTRI

Nutrisystem

$44.14

9.95 (29.10%)

TVTY

Tivity Health

$28.53

-12.07 (-29.73%)

XPER

Xperi

$18.34

5.54 (43.28%)

SSNLF

Samsung

$0.00

(0.00%)

MDRX

Allscripts

$10.15

0.66 (6.95%)

MGNX

MacroGenics

$12.00

-4.44 (-27.01%)

CRZO

Carrizo Oil & Gas

$14.69

-1.2 (-7.55%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

  • 11

    Dec

  • 11

    Dec

  • 12

    Dec

  • 12

    Dec

  • 06

    Jan

KZR

Kezar Life Sciences

$27.79

0.41 (1.50%)

12:05
12/10/18
12/10
12:05
12/10/18
12:05
Conference/Events
Kezar Life Sciences management to meet with Jefferies »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 12

    Dec

T

AT&T

$29.50

-0.64 (-2.12%)

12:05
12/10/18
12/10
12:05
12/10/18
12:05
Options
AT&T call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jan

  • 20

    Mar

BC

Brunswick

$49.53

-0.05 (-0.10%)

12:02
12/10/18
12/10
12:02
12/10/18
12:02
Conference/Events
Brunswick management to meet with Jefferies »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

  • 11

    Dec

AJG

Arthur J. Gallagher

$73.87

-0.74 (-0.99%)

12:01
12/10/18
12/10
12:01
12/10/18
12:01
Hot Stocks
Arthur J. Gallagher acquires Captive Insurance Company Design and Operations »

Arthur J. Gallagher &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

  • 11

    Dec

JP

Jupai Holdings

$5.06

-0.94 (-15.67%)

12:00
12/10/18
12/10
12:00
12/10/18
12:00
Hot Stocks
Jupai Holdings falls -15.8% »

Jupai Holdings is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GSC

Global Geoscience

$23.90

(0.00%)

12:00
12/10/18
12/10
12:00
12/10/18
12:00
Hot Stocks
Global Geoscience falls -16.2% »

Global Geoscience is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MPX

Marine Products

$18.19

-3.4 (-15.75%)

12:00
12/10/18
12/10
12:00
12/10/18
12:00
Hot Stocks
Marine Products falls -18.3% »

Marine Products is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XPER

Xperi

$18.39

5.59 (43.67%)

, SSNLF

Samsung

$0.00

(0.00%)

12:00
12/10/18
12/10
12:00
12/10/18
12:00
Recommendations
Xperi, Samsung analyst commentary  »

Xperi settlement removes…

XPER

Xperi

$18.39

5.59 (43.67%)

SSNLF

Samsung

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 06

    Jan

FAZ

Direxion Financial Bear 3x

$12.50

0.67 (5.66%)

12:00
12/10/18
12/10
12:00
12/10/18
12:00
Hot Stocks
Direxion Financial Bear 3x rises 5.8% »

Direxion Financial Bear…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RCUS

Arcus Biosciences

$13.15

0.9 (7.35%)

12:00
12/10/18
12/10
12:00
12/10/18
12:00
Hot Stocks
Arcus Biosciences rises 8.1% »

Arcus Biosciences is up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SYX

Systemax

$29.66

3.57 (13.68%)

12:00
12/10/18
12/10
12:00
12/10/18
12:00
Hot Stocks
Systemax rises 13.9% »

Systemax is up 13.9%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

GOOG

Alphabet

$1,034.54

-1.98 (-0.19%)

, GOOGL

Alphabet Class A

$1,044.62

-2.37 (-0.23%)

11:58
12/10/18
12/10
11:58
12/10/18
11:58
Periodicals
Google acquires Indian app developer Sigmoid Labs, VB reports »

Google has acquired…

GOOG

Alphabet

$1,034.54

-1.98 (-0.19%)

GOOGL

Alphabet Class A

$1,044.62

-2.37 (-0.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 03

    Mar

ZLAB

Zai Lab

$19.71

-1.15 (-5.51%)

11:57
12/10/18
12/10
11:57
12/10/18
11:57
Conference/Events
Zai Lab management to meet with Jefferies »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

SAGE

Sage Therapeutics

$102.08

-0.55 (-0.54%)

, MRNS

Marinus Pharmaceuticals

$5.15

-0.03 (-0.58%)

11:57
12/10/18
12/10
11:57
12/10/18
11:57
Recommendations
Sage Therapeutics, Marinus Pharmaceuticals analyst commentary  »

JMP boosts Marinus target…

SAGE

Sage Therapeutics

$102.08

-0.55 (-0.54%)

MRNS

Marinus Pharmaceuticals

$5.15

-0.03 (-0.58%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

  • 19

    Mar

TVTY

Tivity Health

$28.25

-12.35 (-30.42%)

, NTRI

Nutrisystem

$44.06

9.87 (28.87%)

11:55
12/10/18
12/10
11:55
12/10/18
11:55
OnTheFly
Tivity plunges as investors digest news of Nutrisystem acquisition »

Shares of Tivity Health…

TVTY

Tivity Health

$28.25

-12.35 (-30.42%)

NTRI

Nutrisystem

$44.06

9.87 (28.87%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

ERJ

Embraer

$21.11

0.04 (0.19%)

11:53
12/10/18
12/10
11:53
12/10/18
11:53
Hot Stocks
Breaking Hot Stocks news story on Embraer 

Embraer trading resumes

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$165.31

-3.06 (-1.82%)

, QCOM

Qualcomm

$57.93

1.93 (3.45%)

11:53
12/10/18
12/10
11:53
12/10/18
11:53
Recommendations
Apple, Qualcomm analyst commentary  »

Qualcomm court win an…

AAPL

Apple

$165.31

-3.06 (-1.82%)

QCOM

Qualcomm

$57.93

1.93 (3.45%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.